Maggie Yuen - 03 Mar 2025 Form 4 Insider Report for Penumbra Inc (PEN)

Role
Chief Financial Officer
Signature
/s/ Emma J. Purdy, as attorney-in-fact for Maggie Yuen
Issuer symbol
PEN
Transactions as of
03 Mar 2025
Net transactions value
-$429,525
Form type
4
Filing time
05 Mar 2025, 19:35:37 UTC
Previous filing
19 Feb 2025
Next filing
18 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PEN Common Stock Sale $70,812 -250 -1.4% $283.25 16,993 03 Mar 2025 Direct F1, F2, F3
transaction PEN Common Stock Sale $85,458 -300 -1.8% $284.86 16,693 03 Mar 2025 Direct F1, F3, F4
transaction PEN Common Stock Sale $168,563 -590 -3.5% $285.70 16,103 03 Mar 2025 Direct F1, F3, F5
transaction PEN Common Stock Sale $143,215 -500 -3.1% $286.43 15,603 03 Mar 2025 Direct F1, F3, F6
transaction PEN Common Stock Sale $103,946 -360 -2.3% $288.74 15,243 03 Mar 2025 Direct F1, F3, F7
transaction PEN Common Stock Options Exercise $142,470 +900 +5.9% $158.30 16,143 05 Mar 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PEN Stock Option (right to buy) Options Exercise $0 -900 -11% $0.000000 7,000 05 Mar 2025 Common Stock 900 $158.30 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $283.09 to $283.49. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F3 A portion of these shares is subject to vesting.
F4 This transaction was executed in multiple trades at prices ranging from $284.82 to $284.93. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $285.33 to $286.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $286.13 to $286.51. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F7 This transaction was executed in multiple trades at prices ranging from $288.68 to $288.90. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F8 All shares are vested and exercisable.